Evidence map›Paper›PMID 29352617›Full record

ArticleNeurobiology of aging2018

High frequency of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis patients from two founder populations sharing the same risk haplotype.

Orly Goldstein, Mali Gana-Weisz, Beatrice Nefussy, Batel Vainer, Omri Nayshool, Anat Bar-Shira, Bryan J Traynor, Vivian E Drory, Avi Orr-Urtreger

Abstract read
In one paragraph

Article in Neurobiology of aging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Distribution of theFrontiers in neurology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Genes · 2021
    Article
  7. Article
  8. Tracing the mutated HTT and haplotype of the African ancestor who spread Huntington disease into the Middle East.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Orly GoldsteinThe Genetic Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Electronic address: orlyg@tlvmc.gov.il.
Mali Gana-WeiszThe Genetic Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Beatrice NefussyNeuromuscular Unit, Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Batel VainerNeuromuscular Unit, Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Omri NayshoolThe Genetic Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Anat Bar-ShiraThe Genetic Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Bryan J TraynorLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.
Vivian E DroryNeuromuscular Unit, Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Avi Orr-UrtregerThe Genetic Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Tel Aviv Sourasky Medical Center · ILNational Institute on Aging · US

Funding

Genome wide SNP analysis in Amyotrophic Lateral SclerosisZIAAG000933 · NIA · NATIONAL INSTITUTE ON AGING · PI TRAYNOR, BRYAN · 2009 to 2025
$9.8M
Intramural NIH HHS ZIA AG000933
6 · The paper itself

Abstract

We characterized the C9orf72 hexanucleotide repeat expansion (RE) mutation in amyotrophic lateral sclerosis (ALS) patients of 2 distinct origins, Ashkenazi and North Africa Jews (AJ, NAJ), its frequency, and genotype-phenotype correlations. In AJ, 80% of familial ALS (fALS) and 11% of sporadic ALS carried the RE, a total of 12.9% of all AJ-ALS compared to 0.3% in AJ controls (odds ratio [OR] = 44.3, p < 0.0001). In NAJ, 10% of fALS and 9% of sporadic ALS carried the RE, a total of 9.1% of all NAJ-ALS compared to 1% in controls (OR = 9.9, p = 0.0006). We identified a risk haplotype shared among all ALS patients, although an association with age at disease onset, fALS, and dementia were observed only in AJ. Variations were identified downstream the repeats. The risk haplotype and these polymorphisms were at high frequencies in alleles with 8 repeats or more, suggesting sequence instability. The different genotype-phenotype correlations and OR, together with the large range in age at onset, suggest that other modifiers and risk factors may affect penetrance and phenotype in ALS.

Indexed as

Genetic Association StudiesAfrica, NorthernAge of OnsetAllelesAmyotrophic Lateral SclerosisC9orf72 ProteinCohort StudiesDNA Repeat ExpansionGene FrequencyHaplotypesHumansJewsMutationPolymorphism, GeneticRiskRisk FactorsC9orf72 ProteinC9orf72 protein, humanAmyotrophic lateral sclerosis (ALS)C9orf72Cohort studies

Identifiers

PMID29352617
PMCPMC5931221
OpenAlexW2776902354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.